Max Healthcare on the Rise – Your Portfolio’s Next Big Vital Sign

Recommendation: ✅ BUYTarget Price (12M): ₹1,400Current Market Price: ₹1,232.80Investment Horizon: Medium to Long Term (6–12 months) Company Overview Max Healthcare Institute Ltd (MHIL) is one of India’s leading hospital chains, offering comprehensive healthcare services across tertiary and quaternary care. With a network of over 17 healthcare facilities, Max Healthcare has established itself as a high-quality,…

Read More

REC Limited: Compelling Growth Story in India’s Energy & Infrastructure Finance

Recommendation: BUY | 12–18 Month Target Upside: 40–60% Recent Highlights & Market Sentiment REC Limited continues to draw strong investor interest after its Board approved a large ₹1.55 lakh crore fundraise in early June 2025. The fundraise aims to support the company’s ambitious growth targets, particularly in renewable energy and infrastructure segments. This follows its…

Read More

Bajaj Finserv: Why Retail Investors Should Buy Ahead of Bonus and Stock Split

Bajaj Finserv: Comprehensive Recommendation The recent monetary policy moves by the RBI, including a 50 bps repo rate cut and a 100 bps CRR cut, have injected approximately ₹2.5 trillion of liquidity into the financial system. This has provided a significant boost to non-banking financial companies (NBFCs), which are generally better positioned than banks to…

Read More

L&T Poised for a Breakout: Strong Order Wins, Earnings Momentum Signal Near-Term Upside

Larsen & Toubro Ltd. Short-Term BUY RecommendationTarget: ₹3,900–3,950 | Time Horizon: 4 weeks | Stop-loss: ₹3,530CMP: ~₹3,620–3,650 Investment Thesis Larsen & Toubro (L&T), India’s largest engineering & construction conglomerate, remains strongly positioned to outperform over the near term, driven by robust order inflows, execution momentum, improving margins, and favorable macro tailwinds. The stock presents an…

Read More